<DOC>
	<DOCNO>NCT00174187</DOCNO>
	<brief_summary>- To assess effect long-term treatment Genotonorm linear growth child short stature receive steroid therapy - To assess effect long term treatment Genotonorm bone mineralisation - To assess effect long term treatment Genotonorm body composition</brief_summary>
	<brief_title>Treatment With Recombinant Human Growth Hormone ( GH ) Children With Short Stature Secondary Long Term Corticoid Therapy</brief_title>
	<detailed_description>This trial terminate 10-Jun-2011 due prolong issue drug accountability data collection discrepancy . The decision terminate base safety concern .</detailed_description>
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Children juvenile arthritis nephrotic syndrome Before puberty Diabetes Type 1 2 Endocrine disease , except well substitute hypothyroidism</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>